Postmastectomy radiotherapy: Questions for the twenty-first century

Journal of Clinical Oncology

Volumn 16, Issue 8, 1998, Pages 2886-2889

  Recht, Abram ^a   Bartelink, Harry ^a   Fourquet, Alain ^a   Fowble, Barbara ^a   Harris, Jay R ^a   Kurtz, John ^a   McCormick, Beryl ^a   Olivotto, Ivo A ^a   Rutqvist, Lars ^a   Solin, Lawrence J ^a   Yarnold, John ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN;

ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; DRUG MEGADOSE; HUMAN; MASTECTOMY; PRIORITY JOURNAL; RECURRENCE RISK; RISK ASSESSMENT;

EID: 0031928698     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.8.2886     Document Type: Article

References (36)

1. Cuzick J, Stewart H, Rutqvist L, et al: Cause-specific mortality in lone-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12:447-453, 1994
2. Recht A: The return (?) of postmastectomy radiotherapy. J Clin Oncol 13:2861-2864, 1995 (editorial)
3. Harris JR, Morrow M: Local management of invasive breast cancer, in Harris JR, Lippman ME, Morrow M, et al (eds): Diseases of the Breast. Philadelphia, PA, Lippincott, 1996, pp 485-545
4. Early Breast Cancer Trialists' Collaborative Group: Effects of radiotherapy and surgery in early breast cancer: An overview of the randomized trials. N Engl J Med 333:1444-1455, 1995
5. Pierce LJ, Lichter AS: Defining the role of post-mastectomy radiotherapy: The new evidence. Oncology (Huntingt) 10:991-1002, 1996
6. Fowble B: Postmastectomy radiotherapy: Then and now. Oncology (Huntingt) 11:213-239, 1997
7. Overgaard M, Hansen PS, Overgaard J, et al: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 337:949-955, 1997
8. Ragaz J, Jackson SM, Le N, et al: Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337:956-962, 1997
9. Ahmann DL, O'Fallon JR, Scanlon PW, et al: A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant clinical trial for patients with breast cancer with special emphasis on the aggressiveness of therapy. Am J Clin Oncol 5:371-381, 1982
10. McArdle CS, Crawford D, Dykes EH, et al: Adjuvant radiotherapy and chemotherapy in breast cancer. Br J Surg 73:264-266, 1986
11. Vélez-García E, Carpenter JT, Moore M, et al: Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: A South-Eastern Cancer Study Group (SEG) trial. Eur J Cancer 28A:1833-1837, 1992
12. Tennvall-Nittby L, Tenegrup I, Landberg T: The total incidence of loco-regional recurrence in a randomized trial of breast cancer TNM stage II: The South Sweden Breast Cancer Trial. Acta Oncol 32:641-646, 1993
13. Arriagada R, Rutqvist LE, Mattsson A, et al: Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol 13:2869-2878, 1995
14. Fowble B, Gray R, Gilchrist K, et al: Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J Clin Oncol 6:1107-1117, 1988
15. Sykes HF, Sim DA, Wong CJ, et al: Local-regional recurrence in breast cancer after mastectomy and adriamycin-based adjuvant chemotherapy: Evaluation of the role of postoperative radiotherapy. Int J Radiat Oncol Biol Phys 16:641-647, 1989
16. Pisansky TM, Ingle JN, Schaid DJ, et al: Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node-positive breast cancer. Cancer 72:1247-1260, 1993
17. Goldhirsch A, Gelber RD, Castiglione M: Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: Patterns and prognoses. J Clin Oncol 6:89-97, 1988
18. Buzdar A, McNeese MD, Hortobagyi GN, et al: Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer? Cancer 65:394-399, 1990
19. Kaufmann M, Jonat W, Abel U, et al: Adjuvant randomized trials of doxorubicin/cyclophosphamide versus doxorubicin/cyclophosphamide/tamoxifen and CMF chemotherapy versus tamoxifen in women with node-positive breast cancer. J Clin Oncol 11:454-460, 1993
20. Chu AM, Kiel K: Comparison of adjuvant postoperative radiotherapy and multiple-drug chemotherapy (CMF-VP) in operable breast cancer patients with more than four positive axillary lymph nodes. Cancer 50:212-218, 1982
21. Recht A, Hayes DF, Eberlein TJ, et al: Local-regional recurrence after mastectomy or breast-conserving therapy, in Harris JR, Lippman M, Morrow M, et al (eds): Diseases of the Breast. Philadelphia, PA, Lippincott, 1996, pp 649-667
22. Recht A, Houlihan MJ: Axillary lymph nodes and breast cancer: A review. Cancer 76:1491-1512, 1995
23. Ewers S-B, Attewell R, Baldetorp B, et al: Flow cytometry analysis and prediction of locoregional recurrences after mastectomy in breast carcinoma. Acta Oncol 31:733-740, 1992
24. Kuske RR, Hayden D, Bischoff R, et al: The impact of extracapsular axillary nodal extension (ECE) with and without irradiation on patterns of failure and survival from breast cancer. Int J Radiat Oncol Biol Phys 36:277, 1996 (suppl 1, abstr)
25. Vicini FA, Horwitz EM, Lacerna MD, et al: The role of regional nodal irradiation in the management of patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 39:1069-1076, 1997
26. Fisher B, Slack NH, Cavanaugh PJ, et al: Postoperative radiotherapy in the treatment of breast cancer: Results of the NSABP clinical trial. Ann Surg 172:711-732, 1970
27. Høst H, Brennhovd IO, Loeb M: Postoperative radiotherapy in breast cancer - Long-term results from the Oslo study. Int J Radiat Oncol Biol Phys 12:727-732, 1986
28. Veronesi U, Banfi A, Salvadori B, et al: Breast conservation is the treatment of choice in small breast cancer: Long-term results of a randomized trial. Eur J Cancer 26:668-670, 1990
29. Kaija H, Maunu P: Tangential breast irradiation with or without internal mammary chain irradiation: Results of a randomized trial. Radiother Oncol 36:172-176, 1995
30. Yamashita T, Hurukawa M, Sekiguchi K, et al: Efficacy of loco-regional lymph nodes irradiation after mastectomy for breast cancer with biopsy proven lymph nodes metastases - A randomized study. Int J Radiat Oncol Biol Phys 36:277, 1996 (suppl 7, abstr)
31. Kiel K, Chang S, Small W, et al: Is it possible to treat the axillary nodes in the same radiation fields covering the breast? - A study to locate the limits of the axillary dissection relative to axillary landmarks in the tangential fields. Int J Radiat Oncol Biol Phys 39:264, 1997 (suppl 2, abstr)
32. Recht A, Siddon RL, Kaplan WD, et al: Three-dimensional internal mammary lymphoscintigraphy: Implications for radiation therapy treatment planning for breast carcinoma. Int J Radiat Oncol Biol Phys 14:477-481, 1988
33. Danoff BF, Galvin JM, Cheg E, et al: The clinical application of CT scanning in the treatment of primary breast cancer, in Ames FC, Blumenschein GR, Montague ED (eds): Current Controversies in Breast Cancer. Austin, TX, University of Texas, 1984, pp 391-397
34. Marks LB, Halperin EC, Prosnitz LR, et al: Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with ≥ 10 positive axillary lymph nodes. Int J Radiat Oncol Biol Phys 23:1021-1026, 1992
35. Freedman GM, Fowble BL, Hanlon AL, et al: Close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger. Int J Radiat Oncol Biol Phys 39:266, 1997 (suppl, abstr)
36. Rose C, Hansen PS, Dombernowsky P, et al: A randomized DBCG trial of adjuvant (adj.) tamoxifen (TAM) + radiotherapy (RT) vs. TAM alone vs. TAM + CMF in postmenopausal breast cancer patients (pts.) with high risk of recurrence. Eur J Cancer 30A:S28, 1994 (suppl 2, abstr)